Eric A. Ross

13.7k total citations · 2 hit papers
219 papers, 8.4k citations indexed

About

Eric A. Ross is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eric A. Ross has authored 219 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Oncology, 51 papers in Surgery and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eric A. Ross's work include Colorectal Cancer Screening and Detection (20 papers), Pancreatic and Hepatic Oncology Research (19 papers) and Global Cancer Incidence and Screening (19 papers). Eric A. Ross is often cited by papers focused on Colorectal Cancer Screening and Detection (20 papers), Pancreatic and Hepatic Oncology Research (19 papers) and Global Cancer Incidence and Screening (19 papers). Eric A. Ross collaborates with scholars based in United States, Switzerland and Russia. Eric A. Ross's co-authors include Douglas D. Schocken, Paul E. Leaverton, John P. Hoffman, Ronald E. Myers, Thomas Wolf, Andrew Balshem, Elin R. Sigurdson, Karen Ruth, Andres J. Klein–Szanto and James C. Watson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Eric A. Ross

213 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence and mortality rate of congestive heart failure in the United States

1992 655 citations Eric A. Ross et al. profile →
Time to Surgery and Breast Cancer Survival in the United States

2015 429 citations Richard J. Bleicher, Karen Ruth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric A. Ross United States	48	3.8k	1.7k	1.5k	1.3k	1.3k	219	8.4k
Robert W. Carlson United States	47	4.6k 1.2×	1.2k 0.7×	925 0.6×	2.3k 1.7×	904 0.7×	158	8.1k
Catherine Hill France	56	2.3k 0.6×	1.4k 0.8×	2.5k 1.6×	1.2k 0.9×	1.5k 1.1×	237	10.8k
Peter E. Schwartz United States	53	3.4k 0.9×	808 0.5×	1.3k 0.9×	1.5k 1.1×	2.7k 2.0×	258	10.3k
Jens C. Eickhoff United States	53	2.7k 0.7×	2.2k 1.2×	846 0.6×	751 0.6×	2.4k 1.8×	373	11.3k
Martin Krapcho United States	10	3.6k 0.9×	2.0k 1.2×	1.3k 0.8×	1.0k 0.8×	1.3k 1.0×	14	8.2k
Matt Hayat United States	5	3.3k 0.9×	1.9k 1.1×	1.2k 0.8×	956 0.7×	1.3k 1.0×	6	7.9k
Richard Herrmann Switzerland	50	4.4k 1.2×	2.0k 1.2×	1.2k 0.8×	1.0k 0.8×	2.0k 1.5×	215	10.0k
Milton P. Eisner United States	5	3.6k 0.9×	1.9k 1.1×	1.3k 0.8×	974 0.7×	1.3k 1.0×	10	8.1k
Kent A. Griffith United States	60	4.3k 1.1×	1.9k 1.1×	1.6k 1.1×	2.7k 2.0×	2.0k 1.5×	277	12.8k
Kerri McPherson United Kingdom	16	2.2k 0.6×	1.7k 1.0×	1.6k 1.1×	713 0.5×	783 0.6×	32	8.3k

Countries citing papers authored by Eric A. Ross

Since Specialization

Citations

This map shows the geographic impact of Eric A. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Ross more than expected).

Fields of papers citing papers by Eric A. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Ross. The network helps show where Eric A. Ross may publish in the future.

Co-authorship network of co-authors of Eric A. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Ross. A scholar is included among the top collaborators of Eric A. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Ross. Eric A. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kellen, Eliane, Carolyn Y. Fang, Eric A. Ross, et al.. (2025). Age at First Full-term Pregnancy and Other Reproductive Factors Are Associated with Mammographic Breast Density in Postmenopausal Women: A Study in Flanders, Belgium. Cancer Research Communications. 5(2). 267–276. 1 indexed citations

Ghatalia, Pooja, Eric A. Ross, Matthew R. Zibelman, et al.. (2025). A phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2).. Journal of Clinical Oncology. 43(5_suppl). 815–815. 2 indexed citations

Localio, A. Russell, Stephanie Chang, Anne R. Meibohm, et al.. (2025). Standardization and Prediction to Control Confounding: Estimating Risk Differences and Ratios for Clinical Interpretations and Decision Making. Annals of Internal Medicine. 178(6). 829–835. 1 indexed citations

Plimack, Elizabeth R., Catherine M. Tangen, Melissa Plets, et al.. (2024). Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial. European Urology. 86(4). 297–300. 7 indexed citations

Matasar, Matthew J., Marcus Messmer, Rashmi Khanal, et al.. (2024). Abstract CT245: Circulating tumor DNA and nivolumab maintenance: A pilot study in diffuse large B cell lymphoma. Cancer Research. 84(7_Supplement). CT245–CT245.

Ruth, Karen, et al.. (2023). ASO Visual Abstract: The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast Conserving Surgery—A Matched Pair Analysis. Annals of Surgical Oncology. 30(7). 4122–4122. 1 indexed citations

Ruth, Karen, et al.. (2023). The Impact of an Electromagnetic Seed Localization Device Versus Wire Localization on Breast-Conserving Surgery: A Matched-Pair Analysis. Annals of Surgical Oncology. 30(7). 4111–4119. 3 indexed citations

Bilušić, Marijo, Renee N. Donahue, Susan Wróblewski, et al.. (2022). A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate Cancer and Prostatic Diseases. 25(4). 735–740. 17 indexed citations

Gong, Yulan, Maria F. Arisi, Lorenzo Gerratana, et al.. (2021). Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). International Journal of Molecular Sciences. 22(16). 8924–8924. 1 indexed citations

10.

Tan, Yinfei, Eleonora Sementino, Mitchell Cheung, et al.. (2020). Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma. Clinical Cancer Research. 27(4). 1200–1213. 38 indexed citations

11.

Litwin, Samuel, et al.. (2017). Two‐sample binary phase 2 trials with low type I error and low sample size. Statistics in Medicine. 36(9). 1383–1394. 5 indexed citations

12.

Meropol, Neal J., Brian L. Egleston, Joanne S. Buzaglo, et al.. (2013). A Web‐based communication aid for patients with cancer. Cancer. 119(7). 1437–1445. 34 indexed citations

13.

Ross, Eric A., Robert G. Uzzo, David Y.T. Chen, et al.. (2012). Assessing the Clinical Role of Genetic Markers of Early-Onset Prostate Cancer among High-Risk Men Enrolled in Prostate Cancer Early Detection. Cancer Epidemiology Biomarkers & Prevention. 21(1). 53–60. 11 indexed citations

14.

Peri, Suraj, Ricardo López de Cicco, Julia Santucci-Pereira, et al.. (2012). Defining the genomic signature of the parous breast. BMC Medical Genomics. 5(1). 46–46. 51 indexed citations

15.

Bellacosa, Alfonso, Andrew K. Godwin, Suraj Peri, et al.. (2010). Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA1 or BRCA2 Mutations. Cancer Prevention Research. 3(1). 48–61. 41 indexed citations

16.

Roussi, Pagona, Kerry A. Sherman, Suzanne M. Miller, et al.. (2009). Enhanced counselling for women undergoing BRCA1/2 testing: Impact on knowledge and psychological distress–results from a randomised clinical trial. Psychology and Health. 25(4). 401–415. 21 indexed citations

17.

Yeung, Anthony T., Xinming Li, Steven H. Seeholzer, et al.. (2008). One-Hit Effects in Cancer: Altered Proteome of Morphologically Normal Colon Crypts in Familial Adenomatous Polyposis. Cancer Research. 68(18). 7579–7586. 34 indexed citations

18.

Barsevick, Andrea M., Susan Montgomery, Karen Ruth, et al.. (2008). Intention to communicate BRCA1/BRCA2 genetic test results to the family.. Journal of Family Psychology. 22(2). 303–312. 39 indexed citations

19.

Montgomery, Bruce, Andres J. Klein–Szanto, Eric A. Ross, & Andrew K. Godwin. (2004). Expression of mutant EGFR in ovarian cancer. Cancer Research. 64. 413–413. 1 indexed citations

20.

Ross, Eric A., et al.. (1997). Modeling adherence to colorectal cancer screening. Rehabilitation Oncology. 15(1). 28–29. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact